Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of LY3337641 in Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT02628028

Public ClinicalTrials.gov record NCT02628028. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 10:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, 2-Part Phase 2 Study to Evaluate the Safety and Efficacy of LY3337641 in Adult Subjects With Rheumatoid Arthritis: The RAjuvenate Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the safety and effectiveness of LY3337641 in adults with rheumatoid arthritis (RA).

Study identification

NCT ID
NCT02628028
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
286 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 21, 2016
Primary completion
Apr 24, 2018
Completion
Aug 14, 2018
Last update posted
Oct 8, 2019

2016 – 2018

United States locations

U.S. sites
15
U.S. states
9
U.S. cities
15
Facility City State ZIP Site status
Desert Medical Advances Palm Desert California 92260 —
Stanford University Hospital Palo Alto California 94304 —
Denver Arthritis Center Denver Colorado 80230 —
Innovative Research of West Florida Clearwater Florida 33756 —
Jeffrey Alper MD Research Naples Florida 34102 —
Sun Coast Clinical Research, Inc New Port Richey Florida 34652 —
Lovelace Scientific Resources Venice Florida 34292 —
Center for Arthritis & Osteoporosis Elizabethtown Kentucky 42701 —
Clayton Medical Research St Louis Missouri 63117 —
Rowan Regional Medical Center Salisbury North Carolina 28144 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28401 —
Articularis Healthcare d/b/a/ Low Country Rheumatology, PA North Charleston South Carolina 29406 —
Accurate Clinical Research League City Texas 77573 —
Accurate Clinical Research Nassau Bay Texas 77058 —
Rheumatology and Immunotherapy Center Franklin Wisconsin 53132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02628028, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2019 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02628028 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →